Archives for July 23, 2007

← 2007

ABI launches new miRNA expression arrays

By Dr Matt Wilkinson

Applied Biosystems (ABI) has launched its TaqMan microRNA (miRNA) assays in array format to help researchers search for miRNA biomarkers more efficiently from smaller samples.

FDA studies outside US minimal, survey reveals

By  Kirsty Barnes

Despite the hype, countries in emerging markets are still very much trailing behind the US in the number of Food and Drug Administration (FDA)-approved studies being conducted, particularly the Asia-pacific, a survey by Parexel reveals.

Codexis expands portfolio with BioCatalytics buyout

By  Dr Matt Wilkinson

Biocatalysis expert Codexis has acquired BioCatalytics for an undisclosed amount to strengthen its off-the-shelf biocatalyst portfolio and give itself a larger 'window to the market'.

MedImmune's antibody gives hope to asthma sufferers

By  Dr Matt Wilkinson

MedImmune has announced that interim Phase I results for its new monoclonal antibody (MAb) suggest that it is well tolerated and shows biological activity in adults with asthma.

The future of oral controlled release

By  Anna Lewcock

The field of oral controlled release drug delivery is constantly evolving and developing, allowing ever more precise and tailored delivery profiles for pharmaceutical drugs.

Bio-Rad tackles the 'SELDI biomarker controversy'

By  Dr Matt Wilkinson

Ever since Bio-Rad's acquisition of Ciphergen's SELDI MS (surface enhanced laser desorption/ionisation mass spectrometry) technology late last year, it has been fighting against the spectre of "controversial" research results obtained using the...